Basel Medical BMGL Ratios (2023-2025)

NASDAQ BMGL
$3.04 -0.06 (-1.94%)
As of: Sep 30, 2026 · 2:23 PM EDT
Reported Financials

Basel Medical Quarterly Ratios

Periods 5 quarters
Latest Dec 2025

Basel Medical ratios data for the quarter ended Dec 2025. These financial ratios cover 5 quarters of results from Dec 2023 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Profitability
EBT Margin 38.09%
EBIT Margin 39.98%
EBITDA Margin 45.19%
Net Margin 26.07%
FCF Margin 0.16%
Efficiency
Inventory AverageInventory Avg. 0.08M0.24M0.32M
Assets AverageAssets Avg. 13.49M14.64M14.94M
Equity AverageEquity Avg. 4.61M
Invested CapitalInvested Cap. 9.75M9.19M12.65M
Leverage & Solvency
Interest Coverage RatioInterest Cover 21.16
Debt Ratio 0.340.620.350.49
Times Interest Earned 21.16
Valuation
Price to BookP/B 8.001.83
Enterprise Value 31.10M8.41M
Market Capitalization 33.44M9.21M
Return Ratios
Return on Sales [ROS]ROS 39.98%

Basel Medical Ratios API

Pull Basel Medical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BMGL&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY